Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later-Reference-Cited by-同舟云学术

Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later

Published:2018-12-03 Issue:1 Volume:33 Page:1-8
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Awad A. George^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/article/10.1007/s40263-018-0588-3/fulltext.html

Reference69 articles.

1. Seeman MV. Schizophrenia and its sequelae. In: Awad AG, Voruganti LNP, editors. Beyond assessment of quality of life in schizophrenia. Switzerland: Springer International Publishing; 2016. p. 3–13.

2. Awad AG, Voruganti LNP, Heselgrave RJ. The aim of antipsychotic medications: what are they and are they being achieved? CNS Drugs. 1995;4:8–16.

3. Singh MM, Smith JM. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance. Dis Nerv Syst. 1976;37:191–7.

4. Van Putten T, May PRA, Marader S, Wittman LA. Subjective response to antipsychotic drugs. Arch Gen Psychiatry. 1981;38:187–90.

5. Van Putten T, May PRA. “Akinetic depression” in schizophrenia. Arch Gen Psychiatry. 1978;15:1101–7.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of single-administration of d-sorbitol pretreatment on the bitterness and continued willingness to take asenapine: a randomized, single-blind, placebo-controlled, crossover trial;BMC Psychiatry;2024-01-30

2. Connectivity alterations of mesostriatal pathways in first episode psychosis;Schizophrenia;2023-03-14

3. Relationship between subjective well-being and aripiprazole: an [11C]raclopride PET study;Scientific Reports;2022-07-15

4. Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials;npj Schizophrenia;2021-09-13

5. Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies;European Psychiatry;2021